Journal of Medicinal Chemistry p. 318 - 325 (1987)
Update date:2022-08-04
Topics:
Bonnaud, Bernard
Cousse, Henri
Mouzin, Gilbert
Briley, Mike
Stenger, Antoine
et al.
A series of 1-aryl-2-(aminomethyl)cyclopropanecarboxylic acid derivatives were synthesized and evaluated as potential antidepressants.Compounds with the Z configuration were synthesized from 1-aryl-2-oxo-3-oxabicyclo<3.1.0>hexane and those with E configuration from (E)-1-phenyl-2-(hydroxymethyl)cyclopropanecarboxylic acid.The compounds were evaluated in animal tests designed to reveal potential antidepressant activity and the existence of undesirable side effects.Several derivatives were more active than imipramine and desipramine.On the basis of its activity in pharmacological animal tests of antidepressant activity and its potential lack of side effects, 1-phenyl-1-<(diethylamino)carbonyl>-2-(aminomethyl)cyclopropane hydrochloride, midalcipran (INN), was selected for further development.This compound is currently in phase III clinical evaluation.
View MoreContact:+1-973-357-0577
Address:10 Taft Rd.
Puyang Willing Chemicals Co.,Ltd.
Contact:86-393-4840366
Address:Puyang Henan China
Xi'an Costrong Pharmaceutical Co., Ltd.
Contact:029- 68576496
Address:Room 2004,Shuibao Building,No.190,South Erhuan Rd, Yanta District,Xi'an,Shaan Xi,China
Contact:+86-28-88523492
Address:714rooms of Time Square, Pujiang County
website:https://www.sinoshiny.com/products
Contact:+86-20-62802632;62802633
Address:Room 330 GIGCAS Building,No.511 Kehua Street,Tianhe District
Doi:10.1016/S0040-4039(01)80916-3
(1985)Doi:10.1002/anie.200801373
(2008)Doi:10.1021/ic800664f
(2008)Doi:10.1248/cpb.33.4836
(1985)Doi:10.1021/jacs.0c08583
(2020)Doi:10.1002/anie.201702861
(2017)